Scientech Research »

Vanda Pharmaceuticals shares owned by Scientech Research

Quarter-by-quarter ownership of Vanda Pharmaceuticals (VNDA) shares owned by Scientech Research from 13F filings

Historical chart of Scientech Research investment in Vanda Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Vanda Pharmaceuticals held by Scientech Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vanda Pharmaceuticals by Scientech Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $171k 25k 6.91

More positions owned by Scientech Research

Applied Digital Corp Com New (APLD)
Wave Life Sciences SHS (WVE)
Echostar Corp Cl A (SATS)
Themes Etf Tr Leverage Shs 2x (CRCG)
Scholar Rock Hldg Corp (SRRK)
Miragen Therapeutics (VRDN)
Figma Class A Com Stk (FIG)
Century Aluminum Company (CENX)
Oklo Com Cl A (OKLO)
Coinbase Global Com Cl A (COIN)
Five Below (FIVE)
Cytomx Therapeutics (CTMX)
Graniteshares Etf Tr 2x Long Coin Dai (CONL)
Snowflake Com Shs (SNOW)
Planet Labs Pbc Com Cl A (PL)

View all positions for Scientech Research

Top funds holding Vanda Pharmaceuticals

BlackRock
Vanguard Group
Renaissance Technologies
AIGH Capital Management
Vanguard Capital Management
Millennium Management
Acadian Asset Management
Dimensional Fund Advisors
AQR Capital Management
Geode Capital Management
Two Sigma Investments
State Street Corporation
Krensavage Asset Management
Jacobs Levy Equity Management
Vanguard Portfolio Management

View all funds holding Vanda Pharmaceuticals